Short-term intensive insulin therapy at diagnosis in type 2 diabetes: Plan for filling the gaps

Jianping Weng, Ravi Retnakaran, Ammini Ariachery C, Linong Ji, Luigi Meneghini, Wenying Yang, Jeong Taek Woo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Short-term intensive insulin therapy is unique amongst therapies for type 2 diabetes because it offers the potential to preserve and improve beta-cell function without additional pharmacological treatment. On the basis of clinical experience and the promising results of a series of studies in newly diagnosed patients, mostly in Asian populations, an expert workshop was convened to assess the available evidence and the potential application of short-term intensive insulin therapy should it be advocated for inclusion in clinical practice. Participants included primary care physicians and endocrinologists. We endorse the concept of short-term intensive insulin therapy as an option for some patients with type 2 diabetes at the time of diagnosis and have identified the following six areas where additional knowledge could help clarify optimal use in clinical practice: (1) generalizability to primary care, (2) target population and biomarkers, (3) follow-up treatment, (4) education of patients and providers, (5) relevance of ethnicity, and (6) health economics.

Original languageEnglish (US)
Pages (from-to)537-544
Number of pages8
JournalDiabetes/Metabolism Research and Reviews
Volume31
Issue number6
DOIs
StatePublished - Sep 1 2015

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Therapeutics
Health Services Needs and Demand
Primary Care Physicians
Patient Education
Primary Health Care
Biomarkers
Economics
Pharmacology
Education
Health
Population

Keywords

  • Consensus
  • Short-term intensive insulin therapy
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Short-term intensive insulin therapy at diagnosis in type 2 diabetes : Plan for filling the gaps. / Weng, Jianping; Retnakaran, Ravi; Ariachery C, Ammini; Ji, Linong; Meneghini, Luigi; Yang, Wenying; Woo, Jeong Taek.

In: Diabetes/Metabolism Research and Reviews, Vol. 31, No. 6, 01.09.2015, p. 537-544.

Research output: Contribution to journalArticle

Weng, Jianping ; Retnakaran, Ravi ; Ariachery C, Ammini ; Ji, Linong ; Meneghini, Luigi ; Yang, Wenying ; Woo, Jeong Taek. / Short-term intensive insulin therapy at diagnosis in type 2 diabetes : Plan for filling the gaps. In: Diabetes/Metabolism Research and Reviews. 2015 ; Vol. 31, No. 6. pp. 537-544.
@article{5199090d40f242a6b6c9a688e8dabfdd,
title = "Short-term intensive insulin therapy at diagnosis in type 2 diabetes: Plan for filling the gaps",
abstract = "Short-term intensive insulin therapy is unique amongst therapies for type 2 diabetes because it offers the potential to preserve and improve beta-cell function without additional pharmacological treatment. On the basis of clinical experience and the promising results of a series of studies in newly diagnosed patients, mostly in Asian populations, an expert workshop was convened to assess the available evidence and the potential application of short-term intensive insulin therapy should it be advocated for inclusion in clinical practice. Participants included primary care physicians and endocrinologists. We endorse the concept of short-term intensive insulin therapy as an option for some patients with type 2 diabetes at the time of diagnosis and have identified the following six areas where additional knowledge could help clarify optimal use in clinical practice: (1) generalizability to primary care, (2) target population and biomarkers, (3) follow-up treatment, (4) education of patients and providers, (5) relevance of ethnicity, and (6) health economics.",
keywords = "Consensus, Short-term intensive insulin therapy, Type 2 diabetes",
author = "Jianping Weng and Ravi Retnakaran and {Ariachery C}, Ammini and Linong Ji and Luigi Meneghini and Wenying Yang and Woo, {Jeong Taek}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/dmrr.2603",
language = "English (US)",
volume = "31",
pages = "537--544",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Short-term intensive insulin therapy at diagnosis in type 2 diabetes

T2 - Plan for filling the gaps

AU - Weng, Jianping

AU - Retnakaran, Ravi

AU - Ariachery C, Ammini

AU - Ji, Linong

AU - Meneghini, Luigi

AU - Yang, Wenying

AU - Woo, Jeong Taek

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Short-term intensive insulin therapy is unique amongst therapies for type 2 diabetes because it offers the potential to preserve and improve beta-cell function without additional pharmacological treatment. On the basis of clinical experience and the promising results of a series of studies in newly diagnosed patients, mostly in Asian populations, an expert workshop was convened to assess the available evidence and the potential application of short-term intensive insulin therapy should it be advocated for inclusion in clinical practice. Participants included primary care physicians and endocrinologists. We endorse the concept of short-term intensive insulin therapy as an option for some patients with type 2 diabetes at the time of diagnosis and have identified the following six areas where additional knowledge could help clarify optimal use in clinical practice: (1) generalizability to primary care, (2) target population and biomarkers, (3) follow-up treatment, (4) education of patients and providers, (5) relevance of ethnicity, and (6) health economics.

AB - Short-term intensive insulin therapy is unique amongst therapies for type 2 diabetes because it offers the potential to preserve and improve beta-cell function without additional pharmacological treatment. On the basis of clinical experience and the promising results of a series of studies in newly diagnosed patients, mostly in Asian populations, an expert workshop was convened to assess the available evidence and the potential application of short-term intensive insulin therapy should it be advocated for inclusion in clinical practice. Participants included primary care physicians and endocrinologists. We endorse the concept of short-term intensive insulin therapy as an option for some patients with type 2 diabetes at the time of diagnosis and have identified the following six areas where additional knowledge could help clarify optimal use in clinical practice: (1) generalizability to primary care, (2) target population and biomarkers, (3) follow-up treatment, (4) education of patients and providers, (5) relevance of ethnicity, and (6) health economics.

KW - Consensus

KW - Short-term intensive insulin therapy

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84941209108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941209108&partnerID=8YFLogxK

U2 - 10.1002/dmrr.2603

DO - 10.1002/dmrr.2603

M3 - Article

C2 - 25196375

AN - SCOPUS:84941209108

VL - 31

SP - 537

EP - 544

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 6

ER -